David Deming bought $10K of Phio Pharmaceuticals stock
By AlphaYouPublished Form 4
Deming David H
Reporting filer
David Deming reported buying 12,000 shares of Phio Pharmaceuticals Corp. for about $10K ($0.84 a share on average). Form 4 filed Nov 12, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value | Deming David H | 2026-11-10 | P | Purchase | 6800 | 0.8395 | 44,600 | 2 days | Filed terms
|
| Common Stock, $.0001 par value | Deming David H | 2026-11-11 | P | Purchase | 5200 | 0.8380 | 49,800 | 1 day | Filed terms
|
Common Stock, $.0001 par value
- Owner
- Deming David H
- Date
- 2026-11-10
- Code
- P
- Action
- Purchase
- Quantity
- 6800
- Price
- 0.8395
- Following holdings
- 44,600
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock, $.0001 par value
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 6800
- transaction Price Per Share: 0.8395
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 44600
- id: F2
- direct Or Indirect Ownership: D
Common Stock, $.0001 par value
- Owner
- Deming David H
- Date
- 2026-11-11
- Code
- P
- Action
- Purchase
- Quantity
- 5200
- Price
- 0.8380
- Following holdings
- 49,800
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock, $.0001 par value
- transaction Date: 2026-11-11
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 5200
- transaction Price Per Share: 0.8380
- id: F3
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 49800
- id: F2
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Deming David H: Director.
- F1: The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.8079 to $0.8600 per share on November 10, 2026. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F2: Includes shares of common stock underlying unvested restricted stock units.
- F3: The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.8269 to $0.8600 per share on November 11, 2026. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Original sources
Prepared automatically from public filing data. Report a correction.